Publication | Open Access
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
134
Citations
28
References
2016
Year
Hematological MalignancyMedicineMalignant Blood DisorderHematologyVivo TolerabilityPathologyNext-generation Xpo1 InhibitorHematological MalignanciesCancer TreatmentOncologyRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1